PAR
Click for more information
8.33% 26.0¢ paradigm biopharmaceuticals limited..

OARSI 2024, page-93

  1. Weazel
    1,014 Posts.
    lightbulb Created with Sketch. 188
    clock Created with Sketch.
    05/05/24
    20:35
    Post #: 73674636
    There is a huge amount of doubt at the moment about FDA approval, will there be non dilutive funding or a CR at a big discount.
    If all of those doubts are dismissed I have no doubt there will be a positive rerate.
    We live in hope
    PAR Price at posting: 24.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.0¢ 		Change
0.020(8.33%) 		Mkt cap ! $90.94M
Open High Low Value Volume
24.5¢ 26.0¢ 24.5¢ $195.9K 781.9K

Buyers (Bids)

No. Vol. Price($)
2 38000 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 102892 9
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.